Reddy Life Sciences Profile
Key Indicators
- Authorised Capital ₹ 0.50 M
- Paid Up Capital ₹ 0.50 M
- Company Age 21 Year, 1 Month
- Last Filing with ROC 31 Mar 2024
About Reddy Life Sciences
Reddy Life Sciences Private Limited (RLSPL) is a Private Limited Indian Non-Government Company incorporated in India on 17 December 2003 and has a history of 21 years and one month. Its registered office is in Delhi, India.
The Company is engaged in the Trading Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 0.50 M and a paid-up capital of Rs 0.50 M, as per Ministry of Corporate Affairs (MCA) records.
Konda Reddy, Konda Reddy, and Krishnamoorthy Chandru serve as directors at the Company.
Company Details
-
Location
Delhi, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
Social Media-
Corporate Identity Details
-
CIN/LLPIN
U24239DL2003PTC123574
-
Company No.
123574
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
17 Dec 2003
-
Date of AGM
30 Sep 2024
-
Date of Balance Sheet
31 Mar 2024
-
Listing Status
Unlisted
-
ROC Code
Roc Delhi
Industry
Who are the key members and board of directors at Reddy Life Sciences?
Board Members (3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Konda Reddy
|
Director | 17-Dec-2003 | Current |
|
Konda Reddy
|
Director | 17-Dec-2003 | Current |
|
Krishnamoorthy Chandru
|
Director | 09-Apr-2007 | Current |
Financial Performance of Reddy Life Sciences.
Reddy Life Sciences Private Limited, for the financial year ended 2016, experienced no change in revenue, with a 0% increase. The company also saw a no change in profitability, with a 0% increase in profit. The company's net worth witnessed no change by increase of 0%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Reddy Life Sciences?
In 2016, Reddy Life Sciences had a promoter holding of 99.99% and a public holding of 0.01%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
-
Reddy Seeds Private LimitedKonda Reddy and Konda Reddy are mutual person
-
Reddy Pharmaceuticals LimitedKonda Reddy is a mutual person
-
Reddy LimitedKonda Reddy and Konda Reddy are mutual person
-
Reddy Holdings Private LimitedKonda Reddy and Konda Reddy are mutual person
-
Reddy Dairy Private LimitedKonda Reddy and Konda Reddy are mutual person
-
Reddy Biotec LimitedKonda Reddy and Konda Reddy are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Reddy Life Sciences?
Unlock and access historical data on people associated with Reddy Life Sciences, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Reddy Life Sciences, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Reddy Life Sciences's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.